Toshihito Hirai

All Publications

• Treatment of Donors with Death Receptor 3 Agonistic Fusion Protein TL1A-Ig (with and Without Low Dose IL-2) Leads to Regulatory T Cell Expansion and Activation with Reduction in Graft-Versus-Host Disease Mayers, M., Maas-Bauer, K., Nishikii, H., Simonetta, F., Alvarez, M., Hirai, T., Turkoz, M., Baker, J., Negrin, R. S. ELSEVIER SCIENCE INC. 2018: S191–S192

  View details for Web of Science ID 000425476000255

• IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells Mayers, M., Simonetta, F., Lee, A. W., Hirai, T., Maas-Bauer, K., Alvarez, M., Turkoz, M., Baker, J., Meyer, E., Negrin, R. S. ELSEVIER SCIENCE INC. 2018: S166–S167

  View details for Web of Science ID 000425476000220